The penny stock name said the investment will be used to purchase cryptocurrency to be held on the company balance sheet.
By Francisco Rodrigues, AI Boost|Edited by Stephen Alpher
Oct 6, 2025, 2:54 p.m.

- Leap Therapeutics announced a $58.9 million private investment led by Winklevoss Capital.
- The investment will be used to purchase cryptocurrency as part of a plan to hold crypto on Leap’s balance sheet, in addition to supporting clinical development of its cancer drug candidates.
- Shares of the penny stock rose 25%.
Shares of Leap Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer announced a $58.9 million private investment led by Winklevoss Capital to kickstart a crypto treasury strategy.
The investment, structured as a private placement, includes common shares and warrants priced at $0.61439 per unit. Winklevoss Capital, founded by Cameron and Tyler Winklevoss, will also gain two board seats at Leap.
STORY CONTINUES BELOW
Exactly which cryptos would be purchased was not disclosed.
Leap, known for its immuno-oncology therapies, said it will use a portion of the capital to purchase cryptocurrency as part of a longer-term plan to hold crypto on its balance sheet. The rest will support clinical development of its drug candidates.
The deal places Leap among a growing list of public companies using crypto as a treasury reserve. Leap said more details on its digital asset strategy will be announced in the near future and didn’t detail which assets it plans on acquiring.
Shares were higher by 25% in Monday morning trade.
AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk’s full AI Policy.
More For You
Sep 9, 2025
Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025
What to know:
- Combined spot and derivatives trading on centralized exchanges surged 7.58% to $9.72 trillion in August, marking the highest monthly volume of 2025
- Gate exchange emerged as major player with 98.9% volume surge to $746 billion, overtaking Bitget to become fourth-largest platform
- Open interest across centralized derivatives exchanges rose 4.92% to $187 billion
More For You
By Helene Braun, AI Boost|Edited by Stephen Alpher
9 minutes ago

Options flows now shape price direction more than spot trades as institutions lean on Deribit and IBIT to position around volatility.
What to know:
- Bitcoin options open interest has surged to nearly $80 billion in 2025, rivaling the size of the futures market for the first time.
- Deribit and options on BlackRock’s IBIT are now the two dominant vehicles, each attracting different types of traders and strategies.
- FalconX says options flows now play a major force in shaping bitcoin price action, making them essential for reading market sentiment and risk.